Clinical Trials Logo

Hypersensitivity clinical trials

View clinical trials related to Hypersensitivity.

Filter by:

NCT ID: NCT04108637 Completed - Infection Clinical Trials

Allergy Antibiotics And Microbial Resistance

ALABAMA
Start date: July 4, 2019
Phase: N/A
Study type: Interventional

ALBAMA study is designed to find out if the effects of Penicillin allergy assessment pathway (PAAP) intervention is on penicillin prescribing

NCT ID: NCT04108351 Completed - Clinical trials for Healthy Participants

Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone as a Positive Control

Start date: October 7, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to confirm of assay sensitivity of Driving Simulator by positive control

NCT ID: NCT04105933 Completed - Domestic Violence Clinical Trials

Culturally Sensitive Cognitive Behavioural Therapy for the Survivors of Intimate Partner Violence (IPV)

Start date: March 12, 2017
Phase: N/A
Study type: Interventional

Women experience negative psychological outcomes long after the violent relationship has ended. Women suffer constant trauma and psychological distress being in emotional and mentally abusive relationship. Present study developed Culturally sensitive cognitive-behaviour therapy (CBT) to fit the client's cultural identity, context, and preferences.

NCT ID: NCT04104828 Completed - Allergic Rhinitis Clinical Trials

Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants

Start date: November 5, 2019
Phase:
Study type: Observational

The primary objective of the pilot study is to compare inflammatory responses in blood sera from patients receiving first allergen immunotherapy (AIT) with aluminium (Alum), microcrystalline tyrosine (MCT), or a combination of MCT and monophosphoryl lipid A (MPLA) as adjuvants. The AIT products are containing allergen extracts of grass and tree pollen). Blood is collected before as wells as one day, seven days, and 6-7 weeks after first AIT, and the blood is analysed for content of inflammatory proteins and antibodies.

NCT ID: NCT04091776 Not yet recruiting - Hip Fractures Clinical Trials

CT Scan in Per-trochanteric Fractures

Start date: January 2020
Phase: N/A
Study type: Interventional

To assess the importance Of Ct scan in the prediction of fixation failure of per-trochanteric fractures

NCT ID: NCT04091256 Completed - Clinical trials for Dentinal Hypersensitivity

Treatment of Tooth Sensitivity With the Use of Biorepair Toothpaste

Start date: January 18, 2019
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to evaluate the effect of desensitizing toothpaste containing zinc-carbonate hydroxyapatite nanocrystals in reducing or controlling DH after 8 weeks of treatment

NCT ID: NCT04091204 Recruiting - Clinical trials for BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study

MITO 31
Start date: July 4, 2019
Phase: Phase 2
Study type: Interventional

The aim of the study is to explore a prognostic clinical and molecular biomarker profile in a population of BRCA wild-type recurrent high-grade ovarian cancer patients treated with olaparib as maintenance after response to a platinum based therapy as platinum sensitive recurrence treatment.

NCT ID: NCT04090203 Active, not recruiting - Clinical trials for Peanut Hypersensitivity

Boiled Peanut Oral Immunotherapy

BPOIT
Start date: November 5, 2019
Phase: Phase 1
Study type: Interventional

Prospective Phase 1 clinical trial providing proof of concept data on boiled peanut oral immunotherapy (OIT) for the treatment of peanut allergy in children. The investigators hypothesize that the proportion of subjects successfully desensitized with boiled peanut OIT is greater than the theoretical placebo rate of 20%.

NCT ID: NCT04088981 Suspended - Clinical trials for Diabetes Mellitus, Type 2

Effect of a Dietary Intervention on Intracellular Lipid Levels, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes

Start date: July 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects of a low-fat, plant-based dietary intervention and a portion-controlled dietary intervention (compliant with current American Diabetes Association (ADA) guidelines) on changes in intramyocellular and hepatocellular lipid content in adults with type 2 diabetes. Changes in insulin sensitivity and glycemic control will also be assessed in this study. The study duration is 44 weeks.

NCT ID: NCT04085705 Recruiting - Diabetic Foot Clinical Trials

The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)

PAID
Start date: September 17, 2019
Phase:
Study type: Observational

Rationale: Foot ulcers among diabetics are common. The presence of a contact allergy limits the healing process. Contact allergies for wound dressings are common among patients with ulcers caused by venous insufficiency but less is known about contact allergies in diabetic patients with ulcers. Objective: To determine the prevalence of contact allergies for wound dressings in patients with diabetic foot ulcers. Study design: A prospective multicenter study. Study population: Patients (n=139) with diabetic foot ulcers caused by type 1 or 2 diabetes mellitus treated at Rijnstate Hospital Arnhem, the Netherlands. Main study parameters/endpoints: The primary study parameter is the presence of contact allergies for wound dressings. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: An allergy test is standard procedure at Rijnstate Hospital, there is no direct technique-related burden or risk for the patient. In addition, wound dressings can be adjusted in patients where a contact allergy is determined which will benefit the prognosis of these patients. The data of this study will give insight in the prevalence of contact allergies for wound dressings in patients with diabetic foot ulcers.